新城控股(601155.SH)控股股東解除質押5900萬股
格隆匯8月19日丨新城控股(601155.SH)公佈,2017年8月16日,公司控股股東富域發展將其持有的公司5900萬股限售流通股票質押給華寶信託,質押到期日為2019年8月18日。因約定的質押到期日為非工作日,富域發展與華寶信託協商一致於2019年8月16日解除上述股份的質押。本次質押解除5900萬股,佔公司總股本的2.61%,股份質押解除手續已於2019年8月16日辦理完畢。
截至本公告日,富域發展持有公司股份13.78億股,為無限售條件流通股,佔公司總股本的61.06%,本次解質後剩餘被質押4.88億股,佔其持股總數的35.41%,佔公司總股本的21.62%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.